Matinas BioPharma Holdings, Inc.

Matinas BioPharma Holdings, Inc.

MTNB
Matinas BioPharma Holdings, Inc.US flagNew York Stock Exchange American
0.28
USD
-0.03
- -
1.56MMarket Cap

Matinas BioPharma Holdings, Inc. (MTNB) Stock Split History

Learn about Matinas BioPharma Holdings, Inc.'s most recent 1-for-50 basis stock split on September 03, 2024. Understand the impact on shareholders and the company's market position.

APIChatGPT

Latest Stock Split Details

Key information about Matinas BioPharma Holdings, Inc.'s most recent stock split

Split Date: 2024-09-03
Split Ratio: 1:50
Price Before Split: $0.08
Price After Split: $0.00

Developer API

Get MTNB split history as JSON

Dates, ratios, split factors, and pre/post-split prices from a single REST call. Look up by ticker, CIK, CUSIP, or ISIN. Free tier, no scraping.

GETapi.roic.ai/v2/stock-splits/MTNB

Impact of the Stock Split

Understanding what this means for shareholders

  • The total value of your investment remains the same
  • You now own 50.00 times fewer shares (a 1:50 ratio)
  • The price per share is increased proportionally

Historical Stock Splits

A comprehensive history of Matinas BioPharma Holdings, Inc.'s stock splits

DateRatioIs Reverse SplitPrice Before SplitPrice After Split
2024-09-031:50Yes$0.08$0.00

About Matinas BioPharma Holdings, Inc.

Company overview and industry information

Matinas BioPharma Holdings, Inc. (MTNB) operates in the Biotechnology industry. The recent 1-for-50 reverse stock split is part of the company's strategy to adjust its share price and potentially meet stock exchange listing requirements.

Biotechnology
Go to Matinas BioPharma Holdings, Inc. Summary

Last updated: 7/22/2026

This information is for educational purposes only. Always consult with a financial advisor before making investment decisions.